Role of robot-assisted laparoscopy in deep infiltrating endometriosis with bowel involvement: a systematic review and application of the IDEAL framework
International Journal of Colorectal Disease · 2024
DOI: 10.1007/s00384-024-04669-w ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Colorectal Disease, 2024. Verfasst von Hwa Ian Ong und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Melbourne, Melbourne, Australia. hwaia3@gmail.com. Hauptthemen laut MEDLINE: Endometriosis, Robotic Surgical Procedures, Laparoscopy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
This review aims to evaluate the feasibility of robot-assisted laparoscopic surgery (RALS) as an alternative to standard laparoscopic surgery (SLS) for the treatment of bowel deep-infiltrative endometriosis. Additionally, it aims to provide guidance for future study design, by gaining insight into the current state of research, in accordance with the IDEAL framework.
Method
A systematic review was conducted to identify relevant studies on RALS for bowel deep infiltrating endometriosis in Medline, Embase, Cochrane Library and PubMed databases up to August 2023 and reported in keeping with PRISMA guidelines. The study was registered with PROSPERO Registration: CRD42022308611 Results Eleven primary studies were identified, encompassing 364 RALS patients and 83 SLS patients, from which surgical details, operative and postoperative outcomes were extracted. In the RALS group, mean operating time was longer (235 ± 112 min) than in the standard laparoscopy group (171 ± 76 min) ( p < 0.01). Patients in the RALS group experienced a shorter hospital stay (5.3 ± 3.5 days vs. 7.3 ± 4.1 days) ( p < 0.01), and appeared to have fewer postoperative complications compared to standard laparoscopy. Research evidence for RALS in bowel DE is at an IDEAL Stage 2B of development.
Conclusion
RALS is a safe and feasible alternative to standard laparoscopy for bowel endometriosis treatment, with a shorter overall length of stay despite longer operating times. Further robust randomized trials recommended to delineate other potential advantages of RALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Melbourne, Melbourne, Australia. hwaia3@gmail.com.
- Department of Colorectal Surgery, Austin Health, Melbourne, Australia. hwaia3@gmail.com.
- University of Melbourne, Melbourne, Australia.
- Department of Colorectal Surgery, Austin Health, Melbourne, Australia.
- Department of Colorectal Surgery, University Hospital Limerick, Limerick, Ireland.
- Department of Gynaecology Surgery, University Hospital Limerick, Limerick, Ireland.
ORCID-Profile: Hwa Ian Ong
Zitieren
APA
Ong, H. I., Shulman, N., Nugraha, P., Wrenn, S., Nally, D., Peirce, C., Mahmood, U., McCormick, J., Proud, D., Warrier, S., Fleming, C., & Mohan, H. (2024). Role of robot-assisted laparoscopy in deep infiltrating endometriosis with bowel involvement: a systematic review and application of the IDEAL framework. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04669-w
Vancouver
Ong HI, Shulman N, Nugraha P, Wrenn S, Nally D, Peirce C, et al. Role of robot-assisted laparoscopy in deep infiltrating endometriosis with bowel involvement: a systematic review and application of the IDEAL framework. International Journal of Colorectal Disease. 2024. doi:10.1007/s00384-024-04669-w
BibTeX
@article{Ong2024,
author = {Ong, Hwa Ian and Shulman, Nastassia and Nugraha, Patrick and Wrenn, Stephen and Nally, Deirdre and Peirce, Colin and Mahmood, Uzma and McCormick, Jacob and Proud, David and Warrier, Satish and Fleming, Christina and Mohan, Helen},
title = {Role of robot-assisted laparoscopy in deep infiltrating endometriosis with bowel involvement: a systematic review and application of the IDEAL framework},
journal = {International Journal of Colorectal Disease},
year = {2024},
doi = {10.1007/s00384-024-04669-w}
}
EUVIMED